Cibus shares surge 10.64% premarket after signing non-binding LOI with Interoc to commercialize herbicide-tolerant rice traits in Latin America.

Tuesday, Jan 6, 2026 4:26 am ET1min read
CBUS--
Cibus surged 10.64% in premarket trading following the announcement of a non-binding Letter of Intent (LOI) with Interoc to commercialize herbicide-tolerant (HT) rice traits across key Latin American markets. The agreement outlines plans for market entry in Ecuador and Colombia by 2027, with phased expansion into Peru, Central America, and the Caribbean. This partnership builds on a 2024 material transfer agreement where Cibus successfully integrated HT traits into Interoc’s rice germplasm. The LOI marks a strategic shift from R&D to commercial execution, positioning Cibus to license its gene-editing-derived traits for revenue generation. The move addresses urgent agricultural needs in Latin America, where weed resistance threatens yields, and aligns with Cibus’ focus on leveraging its Rapid Trait Development System™ to advance sustainable crop solutions.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet